At NINGBO INNO PHARMCHEM CO.,LTD., we specialize in providing high-quality chemical compounds that drive innovation in the pharmaceutical sector. One such compound is 4-[4-[4-(Trifluoromethoxy)phenoxy]piperidin-1-yl]phenol, known by its CAS Number 681482-81-5. This molecule is an indispensable pharmaceutical intermediate, particularly recognized for its role in the Delamanid production process. Delamanid itself is a powerful agent used in the treatment of tuberculosis, a disease that continues to pose a significant threat worldwide.

The chemical structure of this intermediate, C18H18F3NO3, with a molecular weight of 353.34, is designed to facilitate specific reactions in the synthesis pathway of Delamanid. The presence of the trifluoromethoxy group is a notable feature, often imparting enhanced lipophilicity and metabolic stability to drug molecules. This characteristic is crucial for improving the bioavailability and efficacy of the final pharmaceutical product. When clients seek to buy Delamanid Intermediate online, they are looking for reliability and consistent quality, attributes that NINGBO INNO PHARMCHEM CO.,LTD. consistently delivers.

The application of this intermediate extends beyond mere synthesis; it is a testament to the advancements in medicinal chemistry and the ongoing pursuit of effective treatments for diseases like tuberculosis. The reliable synthesis of Delamanid Intermediate ensures that the supply chain for this critical drug remains robust. NINGBO INNO PHARMCHEM CO.,LTD. takes pride in contributing to this chain by offering high purity pharmaceutical intermediates that meet the stringent standards required by the pharmaceutical industry.

Understanding the chemical nuances of compounds like CAS 681482-81-5 is vital for researchers and manufacturers. The specific arrangement of functional groups in the trifluoromethoxy phenoxy piperidino benzenol molecule is what makes it so valuable. Our focus on providing detailed chemical information and support helps our clients optimize their research and manufacturing processes, ensuring the successful development of pharmaceutical intermediates for tuberculosis drugs.